ScholarLens Back to search
2015•DiabetologiaOpen access

Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes

Elza Muscelli, Brenno Astiarraga, Elisabetta Barsotti, Andrea Mari, Freimut Schliess, Leszek Nosek, Tim Heise, Uli C. Broedl, Hans‐Juergen Woerle, Ele Ferrannini

Open full text 26 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Empagliflozin, Metformin, Medicine, Type 2 diabetes, Diabetes mellitus, Human physiology, Internal medicine, Metabolic disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes — Research Paper | ScholarLens